Literature DB >> 23937072

Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis: a comparison with non-ulcerative interstitial cystitis and controls.

Cheng-Ling Lee1, Yuan-Hong Jiang, Hann-Chorng Kuo.   

Abstract

OBJECTIVE: To investigate the suburothelial inflammation and urothelial dysfunction that occurs with ketamine-related cystitis (KC) and interstitial cystitis/bladder pain syndrome (IC/BPS). PATIENTS AND METHODS: Bladder tissues from 16 patients with KC, 17 patients with IC/BPS and 10 control subjects were analysed. Immunofluorescence staining of the junction protein E-cadherin was carried out, and tryptase levels and a TUNEL assay were used to assess mast-cell activation and urothelial apoptosis, respectively. The fluorescence intensity of E-cadherin was measured using the ImageJ method. The percentages of activated mast cells and apoptotic cells were calculated as positive cells per unit area (4 μm(2) ).
RESULTS: The mean (sd) ages of the patients in the KC, IC/BPS and control groups were 25.0 (3.8), 41.3 (13.7) and 50.5 (9.6) years, respectively (P < 0.05). The mean (sd) distributions of E-cadherin in KC (10.1 [11.2]) and IC/BPS (25.1 [16.3]) tissues were significantly lower than in the control tissues (42.4 [16.7]; both P < 0.05). The mean (sd) number of activated mast cells, measured by tryptase signals in the KC (6.5 [3.7]) and IC/BPS (4.6 [3.0]) tissues, were significantly higher than in the control tissues (1.3 [1.12]; both P < 0.05). TUNEL staining showed a significantly higher mean (sd) number of apoptotic cells in KC (4.4 [2.5]) and IC/BPS (2.4 [1.7]) tissues than in control tissues (0.1 [0.3]; both P < 0.05). Tissues from the KC bladders had significantly lower expression of E-cadherin (P = 0.024) and significantly higher numbers of apoptotic cells (P = 0.02) compared with the IC/BPS bladder tissues. Greater numbers of apoptotic cells and lower expression levels of E-cadherin significantly correlated with maximum bladder capacity in the overall patient samples (P < 0.05).
CONCLUSIONS: KC and IC/BPS tissues both showed defective junction protein, increased suburothelial inflammation and increased urothelial cell apoptosis. Decreased expression of E-cadherin and increased apoptosis were more severe in KC than in IC/BPS bladder tissues and these findings were associated with the clinical symptoms of KC and IC/BPS.
© 2013 The Authors. BJU International © 2013 BJU International.

Entities:  

Keywords:  apoptosis; bladder dysfunction; inflammation; ketamine; urothelium

Mesh:

Substances:

Year:  2013        PMID: 23937072     DOI: 10.1111/bju.12256

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  30 in total

1.  Clinical staging of ketamine-associated urinary dysfunction: a strategy for assessment and treatment.

Authors:  Peng Wu; Qiang Wang; Zehai Huang; Junpeng Wang; Qinghui Wu; Tianxin Lin
Journal:  World J Urol       Date:  2016-01-23       Impact factor: 4.226

2.  Intact urothelial barrier function in a mouse model of ketamine-induced voiding dysfunction.

Authors:  Retnagowri Rajandram; Teng Aik Ong; Azad H A Razack; Bryce MacIver; Mark Zeidel; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2016-02-24

Review 3.  Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.

Authors:  Jason Ng; Leanna M W Lui; Joshua D Rosenblat; Kayla M Teopiz; Orly Lipsitz; Danielle S Cha; Jiaqi Xiong; Flora Nasri; Yena Lee; Kevin Kratiuk; Nelson B Rodrigues; Hartej Gill; Mehala Subramaniapillai; Rodrigo B Mansur; Roger Ho; Bing Cao; Roger S McIntyre
Journal:  Psychopharmacology (Berl)       Date:  2021-01-23       Impact factor: 4.530

4.  Special K: once the fun is over an EMT arrives for the bladder.

Authors:  Warren G Hill; Weiqun Yu
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-24

5.  Demonstration of the direct impact of ketamine on urothelium using a tissue engineered bladder model.

Authors:  Michel Bureau; Jérôme Pelletier; Alexandre Rousseau; Geneviève Bernard; Stéphane Chabaud; Stéphane Bolduc
Journal:  Can Urol Assoc J       Date:  2015-09-09       Impact factor: 1.862

6.  The clinical presentation and diagnosis of ketamine-associated urinary tract dysfunction in Singapore.

Authors:  Jacklyn Yek; Palaniappan Sundaram; Hakan Aydin; Tricia Kuo; Lay Guat Ng
Journal:  Singapore Med J       Date:  2015-12       Impact factor: 1.858

7.  A pilot study of urine cytokines in ketamine-associated lower urinary tract symptoms.

Authors:  Rachel Y K Cheung; Jacqueline H S Lee; Symphorosa S C Chan; Dawn W T Liu; K W Choy
Journal:  Int Urogynecol J       Date:  2014-06-28       Impact factor: 2.894

8.  Biological effect of ketamine in urothelial cell lines and global gene expression analysis in the bladders of ketamine‑injected mice.

Authors:  Cheng-Huang Shen; Shou-Tsung Wang; Ying-Ray Lee; Shiau-Yuan Liu; Yi-Zhen Li; Jiann-Der Wu; Yi-Ju Chen; Yi-Wen Liu
Journal:  Mol Med Rep       Date:  2014-10-30       Impact factor: 2.952

9.  Autophagy Alters Bladder Angiogenesis and Improves Bladder Hyperactivity in the Pathogenesis of Ketamine-Induced Cystitis in a Rat Model.

Authors:  Jian-He Lu; Yi-Hsuan Wu; Tai-Jui Juan; Hung-Yu Lin; Rong-Jyh Lin; Kuang-Shun Chueh; Yi-Chen Lee; Chao-Yuan Chang; Yung-Shun Juan
Journal:  Biology (Basel)       Date:  2021-05-30

10.  Effect of inflammatory mediators on ATP release of human urothelial RT4 cells.

Authors:  Kylie J Mansfield; Jessica R Hughes
Journal:  Biomed Res Int       Date:  2014-04-15       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.